Spravato (esketamine) is a nasal spray approved by the FDA for treating adults with treatment-resistant depression and major depressive disorder (MDD) with suicidal thoughts. Spravato offers hope to many people who haven’t responded well to traditional antidepressants, but it also comes with potential side effects, some of which can be serious. It’s crucial for patients and caregivers to understand these possible risks and how they can be managed to ensure a safe treatment experience.
1. Serious Side Effects of Spravato
Although Spravato can be highly effective, it’s important to be aware of its potential side effects. The most serious ones include:
- Sedation and Dizziness: Spravato can cause drowsiness and dizziness, leaving patients feeling extremely tired and disoriented.
- Increased Blood Pressure: Blood pressure may temporarily elevate, posing risks for those with hypertension or heart issues.
- Dissociation: Patients may feel detached or experience hallucinations, though these effects usually fade within a few hours.
- Nausea and Vomiting: Spravato may lead to nausea and vomiting due to its effects on neurotransmitters.
- Bladder and Urinary Issues: Rarely, long-term use can result in urinary tract discomfort or frequent urination.
Given these possible risks, it’s essential to follow a doctor’s guidance closely and to remain in a clinical setting after administration.
2. How to Manage Side Effects from Spravato
Managing Spravato’s side effects involves preparation, monitoring, and a few practical strategies to mitigate discomfort. Here’s what can help:
- Monitoring and Observation: Since sedation, dizziness, and dissociation are some of the most common side effects, it’s critical to remain under medical supervision after receiving Spravato. This allows healthcare providers to monitor for any adverse reactions and ensure that patients can safely leave the clinic once the medication’s effects wear off.
- Plan for Post-Treatment Rest: Since sedation is a common side effect, patients should plan to rest and avoid strenuous activity for at least 24 hours after their Spravato treatment.
- Blood Pressure Monitoring: For patients with existing blood pressure concerns, additional monitoring can help mitigate the risks. Healthcare provider may recommend checking blood pressure more frequently or taking temporary antihypertensive medication to counteract increases.
- Hydration and Eating Light: Since nausea and vomiting can be side effects, eating a light meal and staying hydrated before the treatment can reduce the likelihood of gastrointestinal discomfort. Avoiding alcohol, caffeine, and heavy meals before treatment is also beneficial.
- Breathing and Relaxation Techniques: If dissociation or feelings of detachment arise, grounding techniques such as deep breathing, mindfulness, or focusing on specific objects in the room may help patients regain a sense of stability.
- Communication with Healthcare Providers: Open communication with healthcare providers is essential. Let your healthcare team know about any side affects you experience, even if they seem minor. They can adjust doses, timing, or even frequency of administration to minimize side effects. Additionally, if urinary discomfort arises, speak with your doctor about any symptoms so they can monitor and offer appropriate care.
3. Final Thoughts
Spravato is a promising treatment option for individuals with severe depression, but like any powerful medication, it requires careful management of side effects. By staying informed, preparing for potential side effects, and working closely with a healthcare provider, patients can help manage the risks and increase their chances of a positive treatment experience. With the right support and precautions, Spravato can be a valuable component in managing treatment-resistant depression effectively and safely.